We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$311B
AUM Growth
+$27B
Cap. Flow
-$2.73B
Cap. Flow %
-0.88%
Top 10 Hldgs %
26.14%
Holding
3,413
New
219
Increased
1,869
Reduced
1,057
Closed
98

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$482M
2
SHOP icon
Shopify
SHOP
+$353M
3
INTC icon
Intel
INTC
+$318M
4
NKE icon
Nike
NKE
+$312M
5
UBS icon
UBS Group
UBS
+$309M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$520M
2
ORCL icon
Oracle
ORCL
+$471M
3
CRM icon
Salesforce
CRM
+$452M
4
EOG icon
EOG Resources
EOG
+$360M
5
META icon
Meta Platforms (Facebook)
META
+$246M

Sector Composition

Rank Sector Weight
1 Technology 28.65%
2 Financials 12.19%
3 Healthcare 11.7%
4 Consumer Discretionary 11.15%
5 Industrials 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNA icon
2351
CNA Financial
CNA
$14.1B
$2.21M ﹤0.01%
52,201
+1,289
+3% +$52.5K
FDMT icon
2352
4D Molecular Therapeutics
FDMT
$562M
$2.2M ﹤0.01%
108,750
+1,383
+1% +$18.2K
ETD icon
2353
Ethan Allen Interiors
ETD
$603M
$2.2M ﹤0.01%
68,864
+605
+0.9% +$17.3K
GDEN
2354
DELISTED
Golden Entertainment
GDEN
$2.2M ﹤0.01%
55,027
+666
+1% +$24.1K
ASIX icon
2355
AdvanSix
ASIX
$444M
$2.19M ﹤0.01%
73,182
+697
+1% +$19.4K
ZLAB icon
2356
Zai Lab
ZLAB
$2.62B
$2.19M ﹤0.01%
80,000
TMCI icon
2357
Treace Medical Concepts
TMCI
$309M
$2.19M ﹤0.01%
171,425
-266,168
-61% -$2.69M
FRO icon
2358
Frontline
FRO
$8.85B
$2.18M ﹤0.01%
+108,927
New +$2.25M
ATRI
2359
DELISTED
Atrion Corp
ATRI
$2.17M ﹤0.01%
5,730
-94
-2% -$32.5K
BFC icon
2360
Bank First Corp
BFC
$1.7B
$2.16M ﹤0.01%
24,912
+514
+2% +$42.5K
LFST icon
2361
Lifestance Health
LFST
$4.14B
$2.15M ﹤0.01%
274,426
+3,750
+1% +$24.2K
MODV
2362
DELISTED
ModivCare
MODV
$2.14M ﹤0.01%
48,714
-35,346
-42% -$1.4M
GIC icon
2363
Global Industrial
GIC
$1.49B
$2.14M ﹤0.01%
55,140
+2,809
+5% +$100K
SPY icon
2364
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$2.14M ﹤0.01%
4,500
-132
-3% -$58.8K
GPMT
2365
Granite Point Mortgage Trust
GPMT
$61.2M
$2.13M ﹤0.01%
359,241
+208,594
+138% +$1.05M
AMPL icon
2366
Amplitude
AMPL
$1.41B
$2.13M ﹤0.01%
167,236
+1,463
+0.9% +$16.2K
CBL
2367
CBL Properties
CBL
$1.75B
$2.12M ﹤0.01%
86,977
+14,285
+20% +$319K
TIPT icon
2368
Tiptree Inc
TIPT
$675M
$2.12M ﹤0.01%
111,863
+463
+0.4% +$8.01K
OOMA icon
2369
Ooma
OOMA
$604M
$2.12M ﹤0.01%
197,641
-3,800
-2% -$43.2K
ITOS
2370
DELISTED
iTeos Therapeutics
ITOS
$2.12M ﹤0.01%
193,401
+133,501
+223% +$1.32M
RUSHB icon
2371
Rush Enterprises Class B
RUSHB
$6.14B
$2.11M ﹤0.01%
39,799
+255
+0.6% +$11.5K
GOGO icon
2372
Gogo Inc
GOGO
$492M
$2.11M ﹤0.01%
208,102
-395
-0.2% -$4.19K
SLP icon
2373
Simulations Plus
SLP
$371M
$2.11M ﹤0.01%
47,067
+585
+1% +$23.2K
VIR icon
2374
Vir Biotechnology
VIR
$1.49B
$2.1M ﹤0.01%
208,300
+2,942
+1% +$26.9K
EGO icon
2375
Eldorado Gold
EGO
$9.89B
$2.09M ﹤0.01%
+160,062
New +$1.8M

Similar funds

Nuveen's Q4 2023 Portfolio in Review

As of Q4 2023, Nuveen held 3,413 positions worth $311B, up 9.5% from $284B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nuveen's Q4 2023 filing shows 219 new, 1,869 increased, 1,057 reduced and 98 closed positions. Its largest new stake was CRH: 7,989,897 shares worth $552M. The largest sale was Amazon, an estimated $520M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2023 buy was CRH: 7,989,897 shares worth $552M.
  • Nuveen added most to Intel in Q4 2023, an estimated $318M increase.
  • Nuveen's biggest Q4 2023 reduction was Amazon, cutting an estimated $520M.
  • Nuveen fully exited Activision Blizzard in Q4 2023, selling an estimated $194M.
  • Nuveen's ten largest holdings make up 26% of its $311B portfolio in Q4 2023.
  • Nuveen opened 219 new positions and closed 98 in Q4 2023.
  • Nuveen's portfolio value rose 9.5% quarter-over-quarter to $311B.

Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.